Company Monitoring Page for AstraZeneca

latest headlines for company on cafepharma

Dynavax and AstraZeneca to Advance TLR-9 Agonist Into Clinic for Asthma
Yahoo
Thu, 10/6/11 - 12:03 pm
Tags:
AstraZeneca, Dynavax, toll-like Receptor (TLR) 9 agonist, asthma, AZD 1419
Seeking Diversification Through Drug Company Dividend Stocks
Seeking Alpha
Thu, 10/6/11 - 12:00 pm
Tags:
dividends, JNJ, Pfizer, Novartis, GSK, Merck, Sanofi, Abbott Laboratories, AstraZeneca, Amgen, Eli Lilly, Bristol-Myers Squibb
Pfizer's Selling, Not Buying, Pipeline Drugs?
Motley Fool
Thu, 10/6/11 - 09:29 am
Tags:
Pfizer, patents, tremelimumab, AstraZeneca
Change of heart: Why Pozen now wants to partner its cardiovascular drug
Med City
Wed, 10/5/11 - 10:59 am
Tags:
Pozen, PA32540, AstraZeneca, GSK
FDA to Respond to Bristol-Myers Drug
Yahoo/Zacks.com
Wed, 10/5/11 - 09:58 am
Tags:
FDA, Bristol-Myers Squibb, Dapagliflozin, diabetes, AstraZeneca
Dapagliflozin And Libigel Lead 4 October Healthcare Catalysts
Seeking Alpha
Tue, 10/4/11 - 11:23 am
Tags:
LibiGel, Dapagliflozin, Antares, AstraZeneca, BioSante, Bristol-Myers Squibb, Teva Pharmaceuticals, Pacira
MedImmune In-Licenses Cancer Immunotherapy Tremelimumab from Pfizer
Yahoo
Mon, 10/3/11 - 10:39 am
Tags:
MedImmune, cancer immunotherapy, Pfizer, tremelimumab, AstraZeneca, CTLA-4 monoclonal antibody
Biogen, Teva, Other Drug Makers Face Stock Catalysts in October
Minyanville
Sat, 10/1/11 - 01:59 pm
Tags:
Biogen, Teva Pharmaceuticals, Novartis, Bristol-Myers Squibb, AstraZeneca, Alexion
This Week in Biotech
Motley Fool
Sat, 10/1/11 - 01:50 pm
Tags:
Pharmasset, GSK, Human Genome Sciences, Vertex Pharmaceuticals, Optimer Pharmaceuticals, Cubist Pharmaceuticals, Array Biopharma, AstraZeneca
Array says potential lung cancer treatment misses statistical significance in mid-stage trial
Yahoo/AP
Fri, 09/30/11 - 11:09 am
Tags:
Array, lung cancer, selumetinib, AstraZeneca
AstraZeneca settles Seroquel patent litigation
Marketwatch
Fri, 09/30/11 - 09:27 am
Tags:
Seroquel, AstraZeneca, patents, Handa, Seroquel XR
9 Big Pharmas With The Least Side Effects
Seeking Alpha
Mon, 09/26/11 - 10:57 am
Tags:
Abbott Laboratories, AstraZeneca, Bristol-Myers Squibb, GSK, Eli Lilly, Merck, Novartis, Pfizer, Sanofi
Healthcare: 8 Safe Bets For Dividends And Great Returns
Seeking Alpha
Sat, 09/24/11 - 12:52 pm
Tags:
Abbot, Merck, Eli Lilly, JNJ, Bristol-Myers Squibb, Novartis, Pfizer, AstraZeneca
AstraZeneca Rep Is Sued By Nexium Patients
Pharmalot
Fri, 09/23/11 - 12:28 pm
Tags:
AstraZeneca, Nexium, lawsuits
Top High-Dividend Healthcare Stocks
Seeking Alpha
Thu, 09/22/11 - 02:20 pm
Tags:
dividends, Abbott Laboratories, AstraZeneca, Bristol-Myers Squibb, GSK, JNJ, Eli Lilly, Merck, Novartis, Pfizer, Sanofi
Comparative Effectiveness and the SATURN study Comparing Crestor with Lipitor
Pharmareform
Wed, 09/21/11 - 12:40 pm
Tags:
Crestor, Lipitor, statins, comparative effectiveness, SATURN, AstraZeneca
Pozen looks to fight off Anchen patent challenge
Bizjournals.com
Wed, 09/21/11 - 12:28 pm
Tags:
Anchen, Pozen, patents, vivmo, arthritis, AstraZeneca
Will AstraZeneca Go Deal Hunting?
WSJ Online
Thu, 09/8/11 - 12:49 pm
Tags:
AstraZeneca
FDA Approval Process Sets Higher Bar For What's Treatable
Seeking Alpha
Thu, 09/8/11 - 11:12 am
Tags:
FDA, AstraZeneca, JNJ, Perrigo Company, Regeneron, generics
AstraZeneca pushes research makeover
Boston.com, MA
Wed, 09/7/11 - 11:16 am
Tags:
AstraZeneca, R&D

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.